Geron to shut down stem cell programs, shares fall

Mon Nov 14, 2011 5:04pm EST

Related Topics

(Reuters) - Geron Corp said it will stop development of its stem cell programs to focus more on its cancer drugs, sending its shares down as much as 20 percent in after-market trading.

The move will see Geron cut 66 full-time positions, or about 38 percent of its workforce and stop the development of the first U.S.-approved human embryonic stem cell trial.

The company expects to take a one-time charge of about $5 million in the fourth quarter and about $3 million in the first half of next year.

"In the current environment of capital scarcity and uncertain economic conditions, we intend to focus our resources on advancing our Phase 2 clinical trials of imetelstat and GRN1005," Chief Executive John Scarlett said.

"This would not be possible if we continue to fund the stem cell programs at the current levels."

Geron expects to end the year with cash and investments in excess of $150 million.

Shares of Menlo Park, California-based company were down 20 percent at $1.75 in extended trading. They had closed at $2.20 on Monday on Nasdaq.

(Reporting by Kavyanjali Kaushik in Bangalore; Editing by Viraj Nair)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see
Comments (1)
If stem cell treatments were a boxing match, Embryonic stem cell treatments would be the 500 lb Gorilla and Adult stem cell treatments would be the small, unknown underdog. Today, the Gorilla threw in the towel! What would cause the leading Embryonic stem cell Pharmaceutical company with multiple Embryonic stem cell products in development to end all of their Embryonic stem cell programs? What does it mean for patients who were waiting with desperate hope for the benefits of Embryonic stem cells?

Nov 14, 2011 10:54pm EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.